Umeclidinium and vilanterol is a combination medicine used to prevent airflow obstruction or bronchospasm in people with COPD (chronic obstructive pulmonary disease).
Umeclidinium and vilanterol may also be used for purposes not listed in this medication guide.
Umeclidinium and vilanterol is for use only in people with chronic obstructive pulmonary disease and should not be used to treat asthma.
Vilanterol may increase the risk of death in people with asthma, but the risk in people with COPD is not known. Talk with your doctor about your individual risks and benefits of using this medicine. Follow all patient instructions for safe use.
Umeclidinium and vilanterol will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack.
You should not use this medicine if you are allergic to umeclidinium, vilanterol, or milk proteins. Umeclidinium and vilanterol is for use only in people with COPD and should not be used to treat asthma.
To make sure this medicine is safe for you, tell your doctor if you have:
- heart disease, high blood pressure;
- epilepsy or other seizure disorder;
- liver disease;
- narrow-angle glaucoma;
- diabetes (or ketoacidosis);
- thyroid disorder; or
- bladder obstruction or other urination problems.
FDA pregnancy category C. It is not known whether umeclidinium and vilanterol will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
It is not known whether umeclidinium and vilanterol passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
Do not give this medication to anyone under 18 years old without medical advice.
Anoro Ellipta Side Effects
Call your doctor at once if you have:
- wheezing, choking, or other breathing problems after using this medication;
- fever, chills, cough with yellow or green mucus;
- stabbing chest pain, feeling short of breath;
- tremors, nervousness;
- blurred vision, tunnel vision, eye pain, or seeing halos around lights
- painful or difficult urination, little or no urinating;
- low potassium--confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling; or
- high blood sugar--increased thirst, increased urination, hunger, dry mouth, fruity breath odor, drowsiness, dry skin, blurred vision, weight loss.
- stuffy nose, sinus pain, sore throat;
- mild chest pain;
- diarrhea, constipation;
- muscle spasms; or
- pain in your neck, arms, or legs.
Anoro Ellipta Interactions
Tell your doctor about all medicines you use, and those you start or stop using during your treatment with umeclidinium and vilanterol, especially:
- bladder or urinary medicines such as darifenacin, fesoterodine, oxybutynin, tolterodine, solifenacin;
- bronchodilators such as aclidinium, ipratropium, or tiotropium; or
- cold or allergy medicine that contains an antihistamine.
Anoro Ellipta Dosage
Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.You may need to stop using other COPD medications you have been using in the past on a regular basis. Carefully follow your doctor's dosing instructions.
The usual dose of this medicine is 1 inhalation per day. Use the medicine at the same time each day, and not more than once in a 24-hour period.
Umeclidinium and vilanterol will not work fast enough to treat a bronchospasm attack. Use only a fast-acting inhalation medicine for an attack. Tell your doctor if any of your medicines seem to stop working as well in controlling your COPD.
Umeclidinium and vilanterol is a powder that comes with a special inhaler device preloaded with blister packs containing measured doses of the medicine. The device opens and loads a blister of umeclidinium and vilanterol each time you use the inhaler. Follow the patient instructions provided with the inhaler device.
Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.
Store at room temperature away from moisture, heat, and light. Keep the inhaler device in the sealed foil tray until ready to start using it.
Throw the inhaler device away 6 weeks after you have taken it out of the foil pouch, or if the dose indicator shows a zero, whichever comes first.
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
Overdose symptoms may include fast heart rate, and feeling shaky or short of breath.
Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose. Do not use more than 1 inhalation in a single day.
